‘AI will assist in creating a personalized experience for each individual,’ says Alexey Gubarev

AI assistance will play a significant role.
Alexey Gubarev is a multifaceted individual, serving as an entrepreneur, investor, and philanthropist, with an unwavering dedication to Cyprus. His visionary leadership has played a pivotal role in the transformation of Cyprus into a recognized tech hub. Read on to know his thoughts about innovative technologies and its impact on future of healthcare industry.

I believe it's essential to ensure that every position within the company is filled by qualified individuals who can effectively manage teams and deliver results.

Media 7: Please tell us something about your journey. You've been involved in various tech-related roles; how have those experiences influenced your approach as a leader and board member of leading companies?
Alexey Gubarev:
I began my journey in the internet business at the end of the 1990s, around the turn of the century. In 2002, I relocated to Cyprus with my family and my wife. In 2005, me and my two friends established our first company, which eventually evolved into Servers.com, our first major venture in the cloud industry.

When we initially launched the company with a team of five, I assumed the role of Operational Sales Director. Eventually, as the company grew, I found myself serving as a CEO in this capacity for 13 years. I was responsible for overseeing various aspects of the business, essentially becoming the backbone of the company. Notably, I wasn't just the Chief Executive Officer; I was also one of the primary shareholders from the very beginning. This made our situation quite unique; we never sought external capital, and the individuals who initially founded the company also became its primary investors. It was an unconventional setup, but it worked for us. Essentially, we managed to achieve profitability from day one. For many years, we reinvested all our profits back into the business, allowing it to flourish. The fruits of this endeavor culminated in.

A few years before I resigned the CEO position at Servers.com, I made a decision to invest in startups. My first notable investment was in the famous startup Prisma. This was during its peak popularity in 2016, when it became the number one application according to Google and Apple, with over 120 million downloads in a single year.

In 2016, we established the eventual parent company, Palta, as a means to consolidate our investments in various types of applications under one umbrella. This startup venture proved to be quite successful. Currently, our applications boast over 56 million monthly users and more than 5 million subscribers. Our company now employs over 800 people.

M7: Given your role as a co-founder across three organizations, your wealth of experience in running companies is evident. Could you elaborate on your approach to delegation and perhaps share an illustrative instance where your leadership contributed to a company’s growth through acquisitions or partnerships?
AG:
Okay, at Servers.com, I was responsible for sales, and I managed a team that handled several hundred clients. I focused primarily on B2B sales, and it played a significant role in the company.

While sales were crucial, obtaining B2B customers was our top priority, and I excelled in that area. When we initially started the company from scratch, within just six years, we had already generated over $30 million in revenue.

Now, let's talk about leadership within the company, which centers around the individuals working alongside you, day in and day out. This was a key aspect for me. I believe it's essential to ensure that every position within the company is filled by qualified individuals who can effectively manage teams and deliver results.

In the companies we've built, the team has played a significant role in our success. We've had many team members who have stayed with us for many years. This helped us establish several successful companies in a relatively short span of time.

Personally, when it comes to my strengths, I excel in sales and operations. I have a knack for problem-solving, regardless of the region or circumstances. Additionally, I'm adept at making rapid decisions, even when facing hundreds of choices in a single day. I've applied these skills across various companies and situations over time.

M7: Would you like to share the key challenges and milestones as a co-founder of a health tech startup?
AG:
I firmly believe that the most significant challenge lies in market fit. Simply having an idea, no matter how brilliant it may be, doesn't guarantee success unless it's embraced by the market. Over time, we've observed that some companies achieve immediate success because their ideas resonate right from the start. However, for others, it can take one, two, or even three years to truly discover the right product fit. Even if you have a great product idea within a niche market, it's crucial to understand the final product that people will actually use and be willing to consume on a regular basis. The ultimate success of any startup hinges on its audience and how well you can capture and retain them as users of your product. This is our primary focus; we want our products, regardless of their nature, to be genuinely useful to people.

Read more: 'AI is only as smart as the data and the people behind it', says Kyle Ryan 


The ultimate success of any startup hinges on its audience and how well you can capture and retain them as users of your product.

M7: In your opinion, how do content creation, syndication and advertising contribute to the overall success of an organization in terms of brand awareness?
 AG:
Let’s speak about what content is. In an application like Flo, the content consists of articles and helpful information curated for women—that's one content category. Now, let's shift our focus to another type of content in an application like Lensa, which is primarily a photo and video editor. In this case, content involves filters and visual elements. It's a different kind of content because it caters to the specific needs of the users, allowing them to transform their photos in unique ways. Content within an application can vary significantly depending on its nature. It's not just about the information you provide but also about the actions users can take.

Speaking of marketing, there have been significant changes in marketing strategies over the past seven years. We've seen very few products on the market that have been successful without relying on performance marketing. This has presented a considerable challenge. For example, last year, our application Lensa achieved significant success, becoming the number one application worldwide in December 2022. This was a period when we had the opportunity to gain organic traction as people were actively discussing the app. However, achieving such results has become increasingly rare.

It's essential to understand that in today's market, performance marketing is the key to acquiring customers. You need to be effective with your marketing spend, ensuring that the money invested in advertising brings tangible value. Gone are the days when startups could simply acquire a user base without immediate consideration of financial results. Now, it's all about acquiring users while simultaneously generating a positive financial outcome. Your financial performance must cover marketing costs and more. Investors have become more cautious and demand a clearer path to profitability before committing substantial investments. They no longer throw billions of dollars into a project with the hope of future success.

M7: Can you discuss any innovative technologies that you believe will significantly impact the future of health technology?
AG:
In the realm of health technology, we firmly believe that AI assistance will play a significant role. A case in point is the progress we've seen with advanced models like Chat GPT and Facebook's LLaMA, which were recently released.

It's an exceedingly effective means of communication for people, and it's not just our opinion; the market shares this sentiment. I've noticed a shift in preference from voice-based interactions to text-based ones. Many responses are now generated by AI, and this reflects the direction we're headed. Naturally, it will require some time and a focus on delivering precise answers, especially on specific topics, without touching sensitive information. Nevertheless, it's progressing well in providing users with the information they seek.

This is why we believe AI will shape the future. The conventional approach of navigating through applications with buttons and menus has, in my opinion, become too complex for users. People now prefer having a chat-like interface where they can engage in conversation to obtain the information they desire. It's akin to having a personal friend, whether it's for your personal well-being or academic pursuits. It's about having someone who possesses substantial knowledge about your strengths and weaknesses and guides you in areas that require focus. For example, if you struggle with certain exercises, having AI that understands this and can provide tailored advice to help you improve is invaluable. In one of our applications, Zing, we've even introduced a specialized system where your phone monitors your exercise performance, offering real-time feedback. It simplifies the process, making it more accessible.

The distinguishing factor here is personality. Currently, most applications treat users uniformly and lack personalization. However, I believe that in the future, AI will assist in creating a personalized experience for each individual, catering to their unique needs and preferences.

Read more: Q&A with Matthew Sappern, CEO at PeriGen


It's not just about the information you provide but also about the actions users can take.

M7: Funding is a crucial aspect of startup growth. Can you discuss your experience in securing funding and any advice you have for other health tech entrepreneurs seeking investment?
AG:
Now, it's a challenging period to raise capital, which is something every digital company, regardless of its size, must grasp. Often, many people find it extremely difficult, especially when they are far removed from the market or distant from potential investors.

What I believe is essential, depending on the stage you are at, is to clearly communicate and present to your investors when you expect to generate revenue and achieve possible break-even points. Additionally, your marketing model should be cost-effective from the outset. You can't afford to spend money now and hope to recoup it from customers three or four years down the line. You need to ensure that your marketing investments yield returns relatively quickly, typically within one to two years. We no longer have the luxury of extravagant budgets and prolonged spending.

Equally important is having a strong and efficient team. Effectiveness hinges on how well you manage your spending and deliver on your plans. Based on my personal experience, most startups, even those with brilliant ideas, often struggle to gain the trust of potential investors. This is a significant challenge that underscores the importance of consistency. Sometimes, it's better to be a bit more conservative in your projections and present a more realistic picture.
 
It's amusing, especially when you're just starting with an idea, to present your vision precisely. However, it's crucial to understand that in the initial stages, discussing revenue and profitability might not be relevant. Instead, focus on elements like market size and other key factors pertinent to your current stage. Startups must recognize the importance of concentrating on each stage's specific priorities.

Finally, after finding the perfect product, gaining attention through marketing, and establishing a successful business model, you must be precise about your actions. Avoid painting an overly optimistic picture, as it's often unconvincing to potential investors.

M7: What strategies and initiatives does your non-profit organization employ to fulfill its vision of transforming Cyprus into the leading tech hub of Europe?
AG:
Okay, I co-founded the largest association of IT companies in Cyprus, TechIsland, which is a truly unique example. There's no other company or organization with such a wide scope and impact. This has been my passion for many years, and it's why I've dedicated a significant part of my career to it.

In 2020, we had the opportunity to engage with the government and discuss the potential future of the IT sector in Cyprus. It was in 2021 that we officially established the organization with a growing number of members, including both companies and supportive government initiatives. The goal was to explore how Cyprus could contribute to the future of this industry.

Our efforts proved successful. In 2020, the ICT sector's contribution to the GDP was 8.5%, and by 2022, it had nearly doubled up to 13%. This serves as an excellent example of private sector initiatives working hand in hand with the government to attract more companies to the region. When we started, we were just a few people, but now we have 290 member companies, and the number of people working in the ICT sector in Cyprus, specifically in our organization, is around 25,000, and it's growing every day.

We believe that the ICT sector has a bright future in Cyprus. We have a vision, and with the right approach, the right message, and the support of our community, as well as government officials who have been instrumental in our success, we aim to make the ICT sector a key driver of Cyprus's economy in the next five years. 

ABOUT PALTA

Palta is a dynamic collective of Wellbeing and HealthTech brands. It collaborate with visionary entrepreneurs and exceptional individuals to translate groundbreaking concepts into life-enhancing applications that create a meaningful global influence. With a team of more than 700 professionals, it's presence spans across offices in the UK, US, EU, and Israel. To know more please visit; https://palta.com/.

More C-Suite on deck

Q&A with Anna Baecklund, CTO & Founder at Oppioo

Media 7 | September 21, 2021

Anna Baecklund, CTO & Founder at Oppioo, is a Data Scientist Leader, A skilled communicator capable of explaining complex issues with clarity to diverse audiences. With MSc in engineering physics, Anna is responsible for leading innovation using data science including the development of new insights, advanced modelling techniques, and AI capabilities. With Oppio, An AI companion app, she aims to motivate cancer patients who want to speed up and improve their rehab.

Read More

'AI is only as smart as the data and the people behind it', says Kyle Ryan

Media 7 | May 17, 2023

Kyle Ryan believes that innovative concepts, data-driven insights, precise engineering, and efficient execution combine to create great products. He also believes that leadership is essential for innovation. Read on to know his thoughts on the role of leadership and technology in healthcare industry.

Read More

Q&A with Matthew Sappern, CEO at PeriGen

Media 7 | September 30, 2021

Matthew Sappern, CEO at PeriGen, had served as a corporate officer for Eclipsys Corporation before and during its merger with Allscripts. Leading up to the merger, Sappern served as Eclipsys Senior Vice President of Professional Services, responsible for the company’s $100M consulting, implementation and training P&L. Sappern joined Eclipsys in January 2003, as VP of product development in the software engineering division. Over a time of three years, he came to run 75 percent of the development operation and oversaw the delivery of three critical enterprise software releases in record time for the company.

Read More

Q&A with Anna Baecklund, CTO & Founder at Oppioo

Media 7 | September 21, 2021

Anna Baecklund, CTO & Founder at Oppioo, is a Data Scientist Leader, A skilled communicator capable of explaining complex issues with clarity to diverse audiences. With MSc in engineering physics, Anna is responsible for leading innovation using data science including the development of new insights, advanced modelling techniques, and AI capabilities. With Oppio, An AI companion app, she aims to motivate cancer patients who want to speed up and improve their rehab.

Read More

'AI is only as smart as the data and the people behind it', says Kyle Ryan

Media 7 | May 17, 2023

Kyle Ryan believes that innovative concepts, data-driven insights, precise engineering, and efficient execution combine to create great products. He also believes that leadership is essential for innovation. Read on to know his thoughts on the role of leadership and technology in healthcare industry.

Read More

Q&A with Matthew Sappern, CEO at PeriGen

Media 7 | September 30, 2021

Matthew Sappern, CEO at PeriGen, had served as a corporate officer for Eclipsys Corporation before and during its merger with Allscripts. Leading up to the merger, Sappern served as Eclipsys Senior Vice President of Professional Services, responsible for the company’s $100M consulting, implementation and training P&L. Sappern joined Eclipsys in January 2003, as VP of product development in the software engineering division. Over a time of three years, he came to run 75 percent of the development operation and oversaw the delivery of three critical enterprise software releases in record time for the company.

Read More

Related News

Health Technology

Rudolf Riester GmbH Announces Global Market Launch of Telemedicine Solution, Showcases ri-sonic® E-Stethoscope + eMurmur® AI Integration

Rudolf Riester GmbH | January 29, 2024

Rudolf Riester GmbH, a global leader in medical technology, proudly announces the full market launch of its comprehensive Telemedicine offering. Already in active use across Europe, the Middle East, and Africa, the solution from the trusted Riester brand delivers industry-leading quality and versatility through integration of a broad range of medical devices to meet the needs of diverse user scenarios. "Since its founding 75 years ago, Riester has been a pioneer in providing accurate and efficient diagnostic devices for front-line healthcare. We have brought this passion and expertise to the creation of our telemedicine solution," said Dr. Georgiana Gasquères, Global Business Unit Director, Telemedicine at Riester. "Now we empower healthcare providers worldwide with the tools they need to deliver accurate diagnosis and exceptional care to every patient, everywhere, and to do it more sustainably." Riester is demonstrating its Telemedicine Case and Cart offerings at the Arab Health show in Dubai, 29 January – 1 February 2024, at booth SA.E30. Traveling nurses with South African healthcare innovator EQiGate are already evaluating dozens of patients every week with the Riester Telemedicine Case. "EQiGate selected the Riester Telemedicine solution for its high quality, comprehensiveness, and versatile, Windows-based compatibility with our portfolio of operating applications," stated Braam Kruger, CEO at EQiGate. "The Riester solution integrates seamlessly with our Hospital at Home concept, enabling us to bring the hospital to the patient, a healthcare paradigm shift that yields significant cost and time savings for both the healthcare system and the patient." At Arab Health, Riester is showcasing the integration of their industry-leading ri-sonic® E-stethoscope with the eMurmur® AI platform. Digital auscultation with ri-sonic and eMurmur AI enables the early detection and analysis of heart murmurs, informing better, more timely decisions about treatment pathways. To demonstrate their commitment to raising heart health awareness and improving quality of life through accurate and efficient diagnosis, Riester is offering complimentary advisory heart checks to all exhibition attendees at their booth at Arab Health, conducted by a professional cardiologist. "Our participation at Arab Health reaches beyond showcasing our technological advancements; it is about educating and engaging with the public – including Arab Health attendees – and healthcare professionals," said Irina Zhdanova, CEO of Riester. "By providing free advisory heart checks, we emphasise the significance of regular cardiac health assessments and demonstrate how innovative technology can be a pivotal tool in advancing diagnostic cardiac care to improve health outcomes. This is a perfect way to honor Riester’s 75-year heritage and act on our vision and mission." About Rudolf Riester GmbH Since its founding in Germany in 1948, Rudolf Riester GmbH has been a pioneering force in improving quality of life through accurate and efficient diagnosis on the front-line of healthcare. By developing and manufacturing high-quality, market-leading medical diagnostic products, Riester has earned a global reputation for quality, reliability, and innovation in the healthcare sector, with a presence in over 150 countries. Specializing in diagnostic devices, Riester's product portfolio includes telemedicine solutions as well as stethoscopes, blood pressure monitors, otoscopes, ophthalmoscopes, and other medical equipment. Riester is part of the Halma plc group of companies.

Read More

Healthcare Analytics

Keystone Healthcare Partners Establishes Partnership with Trinity Medical to Expand Emergency Medicine Footprint into Louisiana

Keystone Healthcare Partners | February 05, 2024

Keystone Healthcare Partners a leading provider of emergency medicine, hospital medicine, critical care medicine, and telehealth staffing and management services, as well as revenue cycle management, recently announced that it has formed a partnership with Trinity Medical in Ferriday, Louisiana. Keystone's delivery of emergency medicine services at Trinity Medical will commence on February 1, 2024. This contract represents an exciting expansion of Keystone's regional influence into Louisiana; the company has managed contracts in Mississippi for decades. Glenn Adams, Keystone's CEO & Co-founder, notes, "We are excited to kick off another partnership with a client where we see opportunity for real impact. We've hit the ground running to shore up areas of frustration for the client and bring value-add and innovative solutions, such as Keystone Connect AI technology to the emergency medicine program." While the healthcare landscape has been challenging for rural and critical access hospitals, the two entities share a patient-centered ethos that will be paramount to the partnership. The two entities share a community- and patient-focus that is embodied by Trinity's motto, "People you know, caring for people you love." "We are very excited to start our partnership with Keystone Healthcare," states Keisha Smith, CEO of Trinity. "My goal for Trinity Medical has always been to provide our patients with the best healthcare and customer service possible in the Miss-Lou area. We feel that Keystone shares the same goals that we have and will be a true asset to our hospital. Henry Ford stated, 'Coming together is a beginning, staying together is progress, and working together is success.' We are looking forward to a long lasting, successful partnership with Keystone Healthcare." Trinity Medical, a 23-bed licensed facility, continues to grow and upgrade their services and facilities in addition to recruiting physicians to meet the growing needs of their expanding community. About Keystone Healthcare Keystone Healthcare™ is a leading provider of Emergency Medicine, Hospital Medicine, Critical Care Medicine and Telehealth clinical management services and staffing solutions for hospitals. We efficiently deliver high-quality, patient-centered care through strong physician leadership and involved management that drive our innovative and integrated business model. About Trinity Medical Trinity Medical is operated by Concordia Parish Hospital Service District No. 1. Trinity Medical, formerly Riverland Medical Center, opened in 1964 as Concordia Parish Hospital and has continuously served the residents of the area for more than 55 years. In addition to emergency and acute care, Trinity Medical offers surgical services, diagnostic imaging, infusion center, cardio-respiratory care, gastroenterology, lab services, otolaryngology, urology, and an in-hospital rehabilitation service as well as an extensive range of out-patient services, both diagnostic and for treatment.

Read More

Health Technology

PureHealth Completes Acquisition of UK’s Largest Private Healthcare Group

PureHealth | January 16, 2024

PureHealth, the largest healthcare platform in the Middle East, has announced the successful completion of its strategic acquisition of Circle Health Group, UK’s largest independent operators of hospitals, marking a significant milestone in the company's global expansion strategy. The completion of this deal, which has achieved regulatory approvals in record time, signifies PureHealth’s exceptional operational capabilities and commitment to international growth. The completion of this transaction further strengthens PureHealth’s commitment to becoming a leading global player in healthcare. With a vision aligned with the UAE leadership to promote wellbeing and enhance healthcare services, PureHealth is dedicated to continuously improving patient experience and adopting the most advanced clinical practices. The company’s expansion into the UK healthcare market reflects its focus on advancing the science of longevity and unlocking time for humanity. Hamad Al Hammadi, Chairman of the Board of Directors of PureHealth, said: “We are pleased to complete the acquisition of Circle in record time. This remarkable achievement epitomises PureHealth's operational excellence and strategic adaptability in broadening its international impact. After investing in Ardent Health USA, this is PureHealth’s second international acquisition, and we look forward to building our portfolio internationally.” Farhan Malik, Founder and Managing Director of PureHealth, commented: “Completing the acquisition of Circle is a strategic leap forward for PureHealth. This acquisition is more than an expansion; it's a significant stride towards establishing PureHealth as a global healthcare platform. We are not just investing in the future of healthcare; we are shaping it to be more connected, innovative, and accessible on a global scale. This move aligns with our vision of pioneering a healthier future for all and underscores our commitment to elevating the global position of Abu Dhabi in the healthcare sector and revolutionising healthcare services globally. We look forward to fostering long term partnerships within the UK’s healthcare ecosystem.” Valued at c.USD 1.2 billion before debt, this acquisition marks a significant investment in the future of healthcare, positioning PureHealth at the forefront of international healthcare innovation and service provision. Building upon this significant momentum, PureHealth is advancing its expansion strategy in 2024. This strategic vision includes not only acquisitions in locally, but also international markets building a global healthcare platform. As PureHealth moves forward with its strategic global expansion, it remains committed to its mission of delivering unrivalled healthcare experiences through innovation, technology-driven solutions, and collaboration. This transaction not only enhances PureHealth's services and presence in the international healthcare landscape but also solidifies the company’s position as a leader in the healthcare industry, dedicated to improving lives and fostering healthier communities worldwide, and taking PureHealth from Abu Dhabi to the World. About PureHealth By advancing the Science of Longevity, PureHealth is introducing the healthcare of the future from the United Arab Emirates to the rest of the world. PureHealth is the largest healthcare platform in the Middle East with an ecosystem that challenges lifespans and reimagines health spans. With 25+ hospitals, 100+ clinics, multiple diagnostic centres, health insurance solutions, pharmacies, health tech, procurement, investments and more. With groundbreaking innovations at the forefront of healthcare, the company is on a mission to unlock time for humankind.

Read More

Health Technology

Rudolf Riester GmbH Announces Global Market Launch of Telemedicine Solution, Showcases ri-sonic® E-Stethoscope + eMurmur® AI Integration

Rudolf Riester GmbH | January 29, 2024

Rudolf Riester GmbH, a global leader in medical technology, proudly announces the full market launch of its comprehensive Telemedicine offering. Already in active use across Europe, the Middle East, and Africa, the solution from the trusted Riester brand delivers industry-leading quality and versatility through integration of a broad range of medical devices to meet the needs of diverse user scenarios. "Since its founding 75 years ago, Riester has been a pioneer in providing accurate and efficient diagnostic devices for front-line healthcare. We have brought this passion and expertise to the creation of our telemedicine solution," said Dr. Georgiana Gasquères, Global Business Unit Director, Telemedicine at Riester. "Now we empower healthcare providers worldwide with the tools they need to deliver accurate diagnosis and exceptional care to every patient, everywhere, and to do it more sustainably." Riester is demonstrating its Telemedicine Case and Cart offerings at the Arab Health show in Dubai, 29 January – 1 February 2024, at booth SA.E30. Traveling nurses with South African healthcare innovator EQiGate are already evaluating dozens of patients every week with the Riester Telemedicine Case. "EQiGate selected the Riester Telemedicine solution for its high quality, comprehensiveness, and versatile, Windows-based compatibility with our portfolio of operating applications," stated Braam Kruger, CEO at EQiGate. "The Riester solution integrates seamlessly with our Hospital at Home concept, enabling us to bring the hospital to the patient, a healthcare paradigm shift that yields significant cost and time savings for both the healthcare system and the patient." At Arab Health, Riester is showcasing the integration of their industry-leading ri-sonic® E-stethoscope with the eMurmur® AI platform. Digital auscultation with ri-sonic and eMurmur AI enables the early detection and analysis of heart murmurs, informing better, more timely decisions about treatment pathways. To demonstrate their commitment to raising heart health awareness and improving quality of life through accurate and efficient diagnosis, Riester is offering complimentary advisory heart checks to all exhibition attendees at their booth at Arab Health, conducted by a professional cardiologist. "Our participation at Arab Health reaches beyond showcasing our technological advancements; it is about educating and engaging with the public – including Arab Health attendees – and healthcare professionals," said Irina Zhdanova, CEO of Riester. "By providing free advisory heart checks, we emphasise the significance of regular cardiac health assessments and demonstrate how innovative technology can be a pivotal tool in advancing diagnostic cardiac care to improve health outcomes. This is a perfect way to honor Riester’s 75-year heritage and act on our vision and mission." About Rudolf Riester GmbH Since its founding in Germany in 1948, Rudolf Riester GmbH has been a pioneering force in improving quality of life through accurate and efficient diagnosis on the front-line of healthcare. By developing and manufacturing high-quality, market-leading medical diagnostic products, Riester has earned a global reputation for quality, reliability, and innovation in the healthcare sector, with a presence in over 150 countries. Specializing in diagnostic devices, Riester's product portfolio includes telemedicine solutions as well as stethoscopes, blood pressure monitors, otoscopes, ophthalmoscopes, and other medical equipment. Riester is part of the Halma plc group of companies.

Read More

Healthcare Analytics

Keystone Healthcare Partners Establishes Partnership with Trinity Medical to Expand Emergency Medicine Footprint into Louisiana

Keystone Healthcare Partners | February 05, 2024

Keystone Healthcare Partners a leading provider of emergency medicine, hospital medicine, critical care medicine, and telehealth staffing and management services, as well as revenue cycle management, recently announced that it has formed a partnership with Trinity Medical in Ferriday, Louisiana. Keystone's delivery of emergency medicine services at Trinity Medical will commence on February 1, 2024. This contract represents an exciting expansion of Keystone's regional influence into Louisiana; the company has managed contracts in Mississippi for decades. Glenn Adams, Keystone's CEO & Co-founder, notes, "We are excited to kick off another partnership with a client where we see opportunity for real impact. We've hit the ground running to shore up areas of frustration for the client and bring value-add and innovative solutions, such as Keystone Connect AI technology to the emergency medicine program." While the healthcare landscape has been challenging for rural and critical access hospitals, the two entities share a patient-centered ethos that will be paramount to the partnership. The two entities share a community- and patient-focus that is embodied by Trinity's motto, "People you know, caring for people you love." "We are very excited to start our partnership with Keystone Healthcare," states Keisha Smith, CEO of Trinity. "My goal for Trinity Medical has always been to provide our patients with the best healthcare and customer service possible in the Miss-Lou area. We feel that Keystone shares the same goals that we have and will be a true asset to our hospital. Henry Ford stated, 'Coming together is a beginning, staying together is progress, and working together is success.' We are looking forward to a long lasting, successful partnership with Keystone Healthcare." Trinity Medical, a 23-bed licensed facility, continues to grow and upgrade their services and facilities in addition to recruiting physicians to meet the growing needs of their expanding community. About Keystone Healthcare Keystone Healthcare™ is a leading provider of Emergency Medicine, Hospital Medicine, Critical Care Medicine and Telehealth clinical management services and staffing solutions for hospitals. We efficiently deliver high-quality, patient-centered care through strong physician leadership and involved management that drive our innovative and integrated business model. About Trinity Medical Trinity Medical is operated by Concordia Parish Hospital Service District No. 1. Trinity Medical, formerly Riverland Medical Center, opened in 1964 as Concordia Parish Hospital and has continuously served the residents of the area for more than 55 years. In addition to emergency and acute care, Trinity Medical offers surgical services, diagnostic imaging, infusion center, cardio-respiratory care, gastroenterology, lab services, otolaryngology, urology, and an in-hospital rehabilitation service as well as an extensive range of out-patient services, both diagnostic and for treatment.

Read More

Health Technology

PureHealth Completes Acquisition of UK’s Largest Private Healthcare Group

PureHealth | January 16, 2024

PureHealth, the largest healthcare platform in the Middle East, has announced the successful completion of its strategic acquisition of Circle Health Group, UK’s largest independent operators of hospitals, marking a significant milestone in the company's global expansion strategy. The completion of this deal, which has achieved regulatory approvals in record time, signifies PureHealth’s exceptional operational capabilities and commitment to international growth. The completion of this transaction further strengthens PureHealth’s commitment to becoming a leading global player in healthcare. With a vision aligned with the UAE leadership to promote wellbeing and enhance healthcare services, PureHealth is dedicated to continuously improving patient experience and adopting the most advanced clinical practices. The company’s expansion into the UK healthcare market reflects its focus on advancing the science of longevity and unlocking time for humanity. Hamad Al Hammadi, Chairman of the Board of Directors of PureHealth, said: “We are pleased to complete the acquisition of Circle in record time. This remarkable achievement epitomises PureHealth's operational excellence and strategic adaptability in broadening its international impact. After investing in Ardent Health USA, this is PureHealth’s second international acquisition, and we look forward to building our portfolio internationally.” Farhan Malik, Founder and Managing Director of PureHealth, commented: “Completing the acquisition of Circle is a strategic leap forward for PureHealth. This acquisition is more than an expansion; it's a significant stride towards establishing PureHealth as a global healthcare platform. We are not just investing in the future of healthcare; we are shaping it to be more connected, innovative, and accessible on a global scale. This move aligns with our vision of pioneering a healthier future for all and underscores our commitment to elevating the global position of Abu Dhabi in the healthcare sector and revolutionising healthcare services globally. We look forward to fostering long term partnerships within the UK’s healthcare ecosystem.” Valued at c.USD 1.2 billion before debt, this acquisition marks a significant investment in the future of healthcare, positioning PureHealth at the forefront of international healthcare innovation and service provision. Building upon this significant momentum, PureHealth is advancing its expansion strategy in 2024. This strategic vision includes not only acquisitions in locally, but also international markets building a global healthcare platform. As PureHealth moves forward with its strategic global expansion, it remains committed to its mission of delivering unrivalled healthcare experiences through innovation, technology-driven solutions, and collaboration. This transaction not only enhances PureHealth's services and presence in the international healthcare landscape but also solidifies the company’s position as a leader in the healthcare industry, dedicated to improving lives and fostering healthier communities worldwide, and taking PureHealth from Abu Dhabi to the World. About PureHealth By advancing the Science of Longevity, PureHealth is introducing the healthcare of the future from the United Arab Emirates to the rest of the world. PureHealth is the largest healthcare platform in the Middle East with an ecosystem that challenges lifespans and reimagines health spans. With 25+ hospitals, 100+ clinics, multiple diagnostic centres, health insurance solutions, pharmacies, health tech, procurement, investments and more. With groundbreaking innovations at the forefront of healthcare, the company is on a mission to unlock time for humankind.

Read More

Spotlight

Palta

Palta

Palta is a thriving family of Wellbeing and HealthTech brands. We partner with ambitious founders and exceptional talent to transform innovative ideas into life-changing apps that make a positive impact at a global scale. With over 700 employees on board, our offices stretch across the UK, US, EU an...

Events

Resources